B. 1. Pursnani, S. Korley, F. Gopaul, R. Kanade, P. Chandra et al., Percutaneous Coronary Intervention Versus Optimal Medical Therapy in Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials, Circulation: Cardiovascular Interventions, vol.5, issue.4, pp.476-490, 2012.
DOI : 10.1161/CIRCINTERVENTIONS.112.970954

K. Stergiopoulos and D. Brown, Initial Coronary Stent Implantation With Medical Therapy vs Medical Therapy Alone for Stable Coronary Artery Disease, Archives of Internal Medicine, vol.172, issue.4, pp.312-319, 2012.
DOI : 10.1001/archinternmed.2011.1484

M. Hlatky, D. Boothroyd, D. Bravata, E. Boersma, J. Booth et al., Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials, The Lancet, vol.373, issue.9670, pp.1190-1197, 2009.
DOI : 10.1016/S0140-6736(09)60552-3

R. Hill, A. Boland, R. Dickson, Y. Dündar, A. Haycox et al., Drug-eluting stents: a systematic review and economic evaluation, Health Technology Assessment, vol.11, issue.46, p.221, 2007.
DOI : 10.3310/hta11460

W. Weintraub, E. Mahoney, Z. Zhang, H. Chu, J. Hutton et al., One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial, Heart, vol.90, issue.7, pp.782-788, 2004.
DOI : 10.1136/hrt.2003.015057

D. Cohen, A. Bakhai, C. Shi, L. Githiora, T. Lavelle et al., Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: Results From the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) Trial, Circulation, vol.110, issue.5, pp.508-514, 2004.
DOI : 10.1161/01.CIR.0000136821.99814.43

E. Eisenstein, W. Wijns, J. Fajadet, L. Mauri, R. Edwards et al., Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent, JACC: Cardiovascular Interventions, vol.2, issue.12, pp.1178-1187, 2009.
DOI : 10.1016/j.jcin.2009.10.011

M. Hlatky, W. Rogers, I. Johnstone, D. Boothroyd, M. Brooks et al., Medical Care Costs and Quality of Life after Randomization to Coronary Angioplasty or Coronary Bypass Surgery, New England Journal of Medicine, vol.336, issue.2, pp.92-99, 1997.
DOI : 10.1056/NEJM199701093360203

W. Weintraub, W. Boden, Z. Zhang, P. Kolm, Z. Zhang et al., Cost-Effectiveness of Percutaneous Coronary Intervention in Optimally Treated Stable Coronary Patients, Circulation: Cardiovascular Quality and Outcomes, vol.1, issue.1, pp.12-20, 2008.
DOI : 10.1161/CIRCOUTCOMES.108.798462

W. Group-members, D. Lloyd-jones, R. Adams, T. Brown, M. Carnethon et al., Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2010 update: a report from the American Heart Association, pp.46-215, 2010.
DOI : 10.1161/CIRCULATIONAHA.109.192667

W. Heberden, Some account of a disorder of the breast, Med. Trans. R. Coll. Physicians Lond. 1772, vol.2, p.59

K. Fox, M. Garcia, D. Ardissino, P. Buszman, P. Camici et al., Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology, Eur. Heart J, vol.27, pp.1341-1381, 2006.

C. Norton, V. Georgiopoulou, A. Kalogeropoulos, and J. Butler, Chronic stable angina: pathophysiology and innovations in treatment, Journal of Cardiovascular Medicine, vol.12, issue.3, pp.218-219, 2011.
DOI : 10.2459/JCM.0b013e328343e974

J. Parker and J. Parker, Stable Angina Pectoris: The Medical Management of Symptomatic Myocardial Ischemia, Canadian Journal of Cardiology, vol.28, issue.2, pp.70-80, 2012.
DOI : 10.1016/j.cjca.2011.11.002

P. Ducimetière, J. Ruidavets, M. Montaye, B. Haas, and J. Yarnell, Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study, International Journal of Epidemiology, vol.30, issue.5, pp.1057-1062, 2001.
DOI : 10.1093/ije/30.5.1057

P. Meurin and C. Piot, Y a t-il encore des coronariens stables symptomatiques en France???, Annales de Cardiologie et d'Ang??iologie, vol.53, issue.5, pp.267-271, 2004.
DOI : 10.1016/j.ancard.2004.02.006

H. Tunstall-pedoe, K. Kuulasmaa, M. Mähönen, H. Tolonen, E. Ruokokoski et al., Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations, The Lancet, vol.353, issue.9164, pp.1547-1557, 1999.
DOI : 10.1016/S0140-6736(99)04021-0

F. Lampe, R. Morris, P. Whincup, M. Walker, S. Ebrahim et al., Is the prevalence of coronary heart disease falling in British men?, Heart, vol.86, issue.5, pp.499-505, 2001.
DOI : 10.1136/heart.86.5.499

I. Study and G. , Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial, Lancet, vol.359, pp.1269-1275, 2002.

B. Chaitman, R. Hardison, D. Adler, S. Gebhart, M. Grogan et al., The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease: Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction, Circulation, vol.120, issue.25, pp.2529-2540, 2009.
DOI : 10.1161/CIRCULATIONAHA.109.913111

S. Juul-möller, N. Edvardsson, B. Jahnmatz, A. Rosén, S. Sørensen et al., Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris, The Lancet, vol.340, issue.8833, pp.1421-1425, 1992.
DOI : 10.1016/0140-6736(92)92619-Q

P. Hjemdahl, S. Eriksson, C. Held, L. Forslund, P. Näsman et al., Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS), Heart, vol.92, issue.2, pp.177-182, 2006.
DOI : 10.1136/hrt.2004.057703

P. Poole-wilson, J. Lubsen, B. Kirwan, F. Van-dalen, G. Wagener et al., Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial, The Lancet, vol.364, issue.9437, pp.849-857, 2004.
DOI : 10.1016/S0140-6736(04)16980-8

H. Dargie, I. Ford, and K. Fox, Total Ischaemic Burden European Trial (TIBET): Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina, European Heart Journal, vol.17, issue.1, pp.104-112, 1996.
DOI : 10.1093/oxfordjournals.eurheartj.a014668

C. Pepine, E. Handberg, R. Cooper-dehoff, R. Marks, P. Kowey et al., A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the international verapamil-trandolapril study (INVEST): a randomized controlled trial, ACC Current Journal Review, vol.13, issue.2
DOI : 10.1016/j.accreview.2003.12.023

D. Blanchard, Angor Stable avec ou sans " Courage " . Printemps de la Cardiologie, 2008.

J. Abrams, Chronic Stable Angina, New England Journal of Medicine, vol.352, issue.24, pp.2524-2533, 2005.
DOI : 10.1056/NEJMcp042317

H. Hultgren and P. Peduzzi, Relation of severity of symptoms to prognosis in stable angina pectoris, The American Journal of Cardiology, vol.54, issue.8, pp.988-993, 1984.
DOI : 10.1016/S0002-9149(84)80131-9

P. Cohn, P. Harris, W. Barry, R. Rosati, P. Rosenbaum et al., Prognostic importance of anginal symptoms in angiographically defined coronary artery disease, The American Journal of Cardiology, vol.47, issue.2, pp.233-237, 1981.
DOI : 10.1016/0002-9149(81)90391-X

E. Thaulow and J. Erikssen, Prognostic Implications of Asymptomatic Cardiac Ischemia, Cardiology, vol.85, issue.2, pp.11-15, 1994.
DOI : 10.1159/000177042

L. Campeau, Letter: Grading of angina pectoris, Circulation, vol.54, pp.522-523, 1976.

J. Spertus, P. Jones, M. Mcdonell, V. Fan, and S. Fihn, Health Status Predicts Long-Term Outcome in Outpatients With Coronary Disease, Circulation, vol.106, issue.1, pp.43-49, 2002.
DOI : 10.1161/01.CIR.0000020688.24874.90

M. Hlatky, R. Boineau, M. Higginbotham, K. Lee, D. Mark et al., A brief self-administered questionnaire to determine functional capacity (The Duke Activity Status Index), The American Journal of Cardiology, vol.64, issue.10, pp.651-654, 1989.
DOI : 10.1016/0002-9149(89)90496-7

J. Spertus, J. Winder, T. Dewhurst, R. Deyo, J. Prodzinski et al., Development and evaluation of the Seattle Angina questionnaire: A new functional status measure for coronary artery disease, Journal of the American College of Cardiology, vol.25, issue.2, pp.333-341, 1995.
DOI : 10.1016/0735-1097(94)00397-9

L. Shaw, E. Peterson, L. Shaw, K. Kesler, E. Delong et al., Use of a Prognostic Treadmill Score in Identifying Diagnostic Coronary Disease Subgroups, Circulation, vol.98, issue.16, pp.1622-1630, 1998.
DOI : 10.1161/01.CIR.98.16.1622

A. Trialists-'collaboration, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, vol.324, issue.7329, pp.71-86, 2002.
DOI : 10.1136/bmj.324.7329.71

S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies et al., Effects of an angiotensinconverting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators, N. Engl. J. Med, vol.342, pp.145-153, 2000.

N. Danchin, M. Cucherat, C. Thuillez, E. Durand, Z. Kadri et al., Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction, Archives of Internal Medicine, vol.166, issue.7, pp.787-796, 2006.
DOI : 10.1001/archinte.166.7.787

N. Freemantle, C. J. Young, P. Mason, J. Harrison, and J. , beta Blockade after myocardial infarction: systematic review and meta regression analysis, BMJ, vol.318, issue.7200, pp.1730-1737, 1999.
DOI : 10.1136/bmj.318.7200.1730

O. Flynn, N. Timmis, A. Henderson, R. Rajesh, S. Fenu et al., Management of stable angina: summary of NICE guidance, BMJ, vol.343, issue.aug05 1, p.4147, 2011.
DOI : 10.1136/bmj.d4147

J. Parker and J. Parker, Nitrate Therapy for Stable Angina Pectoris, Survey of Anesthesiology, vol.43, issue.1, pp.520-531, 1998.
DOI : 10.1097/00132586-199902000-00007

V. Arnim and T. , Medical treatment to reduce total ischemic burden: Total ischemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine, Journal of the American College of Cardiology, vol.25, issue.1, pp.231-238, 1995.
DOI : 10.1016/0735-1097(94)00345-Q

G. Knatterud, M. Bourassa, C. Pepine, N. Geller, G. Sopko et al., Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-Week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study, Journal of the American College of Cardiology, vol.24, issue.1, pp.11-20, 1994.
DOI : 10.1016/0735-1097(94)90535-5

K. Fox, I. Ford, P. Steg, M. Tendera, and R. Ferrari, Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial, The Lancet, vol.372, issue.9641, pp.807-816, 2008.
DOI : 10.1016/S0140-6736(08)61170-8

P. Serruys, P. De-jaegere, F. Kiemeneij, C. Macaya, W. Rutsch et al., A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease, New England Journal of Medicine, vol.331, issue.8, pp.489-495, 1994.
DOI : 10.1056/NEJM199408253310801

D. Fischman, M. Leon, D. Baim, R. Schatz, M. Savage et al., A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease, New England Journal of Medicine, vol.331, issue.8, pp.496-501, 1994.
DOI : 10.1056/NEJM199408253310802

U. Sigwart, J. Puel, V. Mirkovitch, F. Joffre, and L. Kappenberger, Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal Angioplasty, New England Journal of Medicine, vol.316, issue.12, pp.701-706, 1987.
DOI : 10.1056/NEJM198703193161201

J. Moses, M. Leon, J. Popma, P. Fitzgerald, D. Holmes et al., Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery, New England Journal of Medicine, vol.349, issue.14, pp.1315-1323, 2003.
DOI : 10.1056/NEJMoa035071

G. Stone, S. Ellis, D. Cox, J. Hermiller, O. Shaughnessy et al., One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial, Circulation, vol.109, issue.16, pp.1942-1947, 2004.
DOI : 10.1161/01.CIR.0000127110.49192.72

A. Kirtane, A. Gupta, S. Iyengar, J. Moses, M. Leon et al., Safety and Efficacy of Drug-Eluting and Bare Metal Stents: Comprehensive Meta-Analysis of Randomized Trials and Observational Studies, Circulation, vol.119, issue.25, pp.3198-3206, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.826479

C. Stettler, S. Wandel, S. Allemann, A. Kastrati, M. Morice et al., Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis, The Lancet, vol.370, issue.9591, pp.937-948, 2007.
DOI : 10.1016/S0140-6736(07)61444-5

S. Nishio, K. Kosuga, K. Igaki, M. Okada, E. Kyo et al., Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly-l-Lactic Acid Coronary Stents: Igaki-Tamai Stents, Circulation, vol.125, issue.19, pp.2343-2353, 2012.
DOI : 10.1161/CIRCULATIONAHA.110.000901

R. Favaloro, Saphenous Vein Autograft Replacement of Severe Segmental Coronary Artery Occlusion, The Annals of Thoracic Surgery, vol.5, issue.4, pp.334-339, 1968.
DOI : 10.1016/S0003-4975(10)66351-5

W. Hueb, P. Soares, B. Gersh, L. César, P. Luz et al., The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease, Journal of the American College of Cardiology, vol.43, issue.10, pp.1743-1751, 2004.
DOI : 10.1016/j.jacc.2003.08.065

W. Hueb, N. Lopes, B. Gersh, P. Soares, L. Machado et al., Five-Year Follow-Up of the Medicine, Angioplasty, or Surgery Study (MASS II): A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease, Circulation, vol.115, issue.9, pp.1082-1089, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.625475

W. Hueb, N. Lopes, B. Gersh, P. Soares, E. Ribeiro et al., Ten-Year Follow-Up Survival of the Medicine, Angioplasty, or Surgery Study (MASS II): A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease, Circulation, vol.122, issue.10, pp.949-957, 2010.
DOI : 10.1161/CIRCULATIONAHA.109.911669

S. Yusuf, D. Zucker, P. Peduzzi, L. Fisher, T. Takaro et al., Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration, The Lancet, vol.344, issue.8922, pp.563-570, 1994.
DOI : 10.1016/S0140-6736(94)91963-1

W. Hueb, G. Bellotti, S. De-oliveira, A. S. De-albuquerque, C. Jatene et al., The Medicine, Angioplasty or Surgery Study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses, Journal of the American College of Cardiology, vol.26, issue.7, pp.1600-1605, 1995.
DOI : 10.1016/0735-1097(95)00384-3

W. Hueb, P. Soares, A. De-oliveira, S. Ariê, S. Cardoso et al., Five-year follow-op of the medicine, angioplasty, or surgery study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis, Circulation, vol.100, pp.107-113, 1999.

P. Soares, W. Hueb, P. Lemos, N. Lopes, E. Martinez et al., Coronary Revascularization (Surgical or Percutaneous) Decreases Mortality After the First Year in Diabetic Subjects but not in Nondiabetic Subjects With Multivessel Disease: An Analysis From the Medicine, Angioplasty, or Surgery Study (MASS II), Circulation, vol.114, issue.1_suppl, pp.420-424, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.000679

W. Boden, R. O-'rourke, K. Teo, P. Hartigan, D. Maron et al., Optimal Medical Therapy with or without PCI for Stable Coronary Disease, New England Journal of Medicine, vol.356, issue.15, pp.1503-1516, 2007.
DOI : 10.1056/NEJMoa070829

A. Schömig, J. Mehilli, A. De-waha, M. Seyfarth, J. Pache et al., A Meta-Analysis of 17 Randomized Trials of a Percutaneous Coronary Intervention-Based Strategy in Patients With Stable Coronary Artery Disease, Journal of the American College of Cardiology, vol.52, issue.11, pp.894-904, 2008.
DOI : 10.1016/j.jacc.2008.05.051

P. Hartigan, J. Giacomini, E. Folland, and A. Parisi, Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study), The American Journal of Cardiology, vol.82, issue.12, pp.1445-1450, 1998.
DOI : 10.1016/S0002-9149(98)00685-7

P. Serruys, F. Unger, J. Sousa, A. Jatene, H. Bonnier et al., Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel Disease, New England Journal of Medicine, vol.344, issue.15, pp.1117-1124, 2001.
DOI : 10.1056/NEJM200104123441502

M. Morice, P. Serruys, A. Kappetein, T. Feldman, E. Ståhle et al., Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial, Circulation, vol.121, issue.24, pp.2645-2653, 2010.
DOI : 10.1161/CIRCULATIONAHA.109.899211

A. Kapur, R. Hall, I. Malik, A. Qureshi, J. Butts et al., Randomized Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Diabetic Patients, Journal of the American College of Cardiology, vol.55, issue.5, pp.432-440, 2010.
DOI : 10.1016/j.jacc.2009.10.014

S. Investigators, Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial, Lancet, vol.360, pp.965-970, 2002.

V. Legrand, P. Serruys, F. Unger, B. Van-hout, M. Vrolix et al., Three-Year Outcome After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease, Circulation, vol.109, issue.9, pp.1114-1120, 2004.
DOI : 10.1161/01.CIR.0000118504.61212.4B

J. Booth, T. Clayton, J. Pepper, F. Nugara, M. Flather et al., Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: Six-Year Follow-Up From the Stent or Surgery Trial (SoS), Circulation, vol.118, issue.4, pp.381-388, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.739144

P. Buszman, S. Wiernek, R. Szymanski, B. Bialkowska, P. Buszman et al., Percutaneous versus surgical revascularization for multivessel coronary artery disease: A single center 10 year follow-up of SOS trial patients, Catheterization and Cardiovascular Interventions, vol.115, issue.3, pp.420-426, 2009.
DOI : 10.1002/ccd.22015

M. Cisowski, J. Drzewiecki, A. Drzewiecka-gerber, A. Jaklik, W. Kruczak et al., Primary stenting versus MIDCAB: preliminary report???Comparision of two methods of revascularization in single left anterior descending coronary artery stenosis, The Annals of Thoracic Surgery, vol.74, issue.4, pp.1334-1339, 2002.
DOI : 10.1016/S0003-4975(02)03971-1

D. Drenth, N. Veeger, J. Grandjean, M. Mariani, A. Van-boven et al., Isolated high-grade lesion of the proximal LAD: a stent or off-pump LIMA?, European Journal of Cardio-Thoracic Surgery, vol.25, issue.4, pp.567-571, 2004.
DOI : 10.1016/j.ejcts.2004.01.015

J. Goy, U. Kaufmann, D. Goy-eggenberger, A. Garachemani, M. Hurni et al., A Prospective Randomized Trial Comparing Stenting to Internal Mammary Artery Grafting for Proximal, Isolated De Novo Left Anterior Coronary Artery Stenosis: The SIMA Trial, Mayo Clinic Proceedings, vol.75, issue.11, pp.1116-1123, 2000.
DOI : 10.4065/75.11.1116

J. Goy, U. Kaufmann, M. Hurni, S. Cook, F. Versaci et al., 10-Year Follow-Up of a Prospective Randomized Trial Comparing Bare-Metal Stenting With Internal Mammary Artery Grafting for Proximal, Isolated De Novo Left Anterior Coronary Artery Stenosis, Journal of the American College of Cardiology, vol.52, issue.10, pp.815-817, 2008.
DOI : 10.1016/j.jacc.2008.05.037

N. Vallier, A. Weill, B. Salanave, and R. Bonser, Coût des trente affections de longue durée pour les bénéficiaires du régime général de l'assurance maladie en, Prat Organ Soins, vol.37, pp.267-83, 2004.

S. Fihn, J. Gardin, J. Abrams, K. Berra, J. Blankenship et al., 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, Journal of the American College of Cardiology, vol.60, issue.24, pp.44-164, 2012.
DOI : 10.1016/j.jacc.2012.07.013

H. Javitz, M. Ward, J. Watson, and M. Jaana, Cost of illness of chronic angina, Am. J. Manag. Care, vol.10, pp.358-369, 2004.

M. Reynolds, D. Frame, R. Scheye, M. Rose, S. George et al., A systematic review of the economic burden of chronic angina, Am. J. Manag. Care, vol.10, pp.347-357, 2004.

H. Porter, Health resource utilization and quality of life outcomes of low-risk coronary artery bypass graft patients: a comparison study, Can. J. Cardiovasc. Nurs. J. Can. En Soins Infirm. Cardio-Vasc, vol.9, pp.10-15, 1998.

C. Guico-pabia, J. Murray, S. Teutsch, A. Wertheimer, and M. Berger, Indirect cost of ischemic heart disease to employers, Am. J. Manag. Care, vol.7, pp.27-34, 2001.

E. Puymirat, A. Chaib, A. Chaudeurge, L. Trinquart, F. Ledru et al., 071 Drug-eluting stents: do we respect the one-label use in our daily practice?, Archives of Cardiovascular Diseases Supplements, vol.3, issue.1, pp.196-204, 2010.
DOI : 10.1016/S1878-6480(11)70073-8

E. Puymirat, D. Blanchard, M. Perier, M. Piadonataccio, M. Gilard et al., Study Design and Baseline Characteristics of the National Observational Study of Diagnostic and Interventional Cardiac Catheterization by the French Society of Cardiology, Am. J. Cardiol, 2013.

D. Favarato, W. Hueb, B. Gersh, P. Soares, L. Cesar et al., Relative Cost Comparison of Treatments for Coronary Artery Disease: The First Year Follow-Up of MASS II Study, Circulation, vol.108, issue.90101, pp.21-23, 2003.
DOI : 10.1161/01.cir.0000087381.98299.7b

D. Mark, W. Pan, N. Clapp-channing, K. Anstrom, J. Ross et al., Quality of Life after Late Invasive Therapy for Occluded Arteries, New England Journal of Medicine, vol.360, issue.8, pp.774-783, 2009.
DOI : 10.1056/NEJMoa0805151

A. Rodriguez, E. Mele, E. Peyregne, F. Bullon, N. Perez-baliño et al., Three-year follow-up of the argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI), Journal of the American College of Cardiology, vol.27, issue.5, pp.1178-1184, 1996.
DOI : 10.1016/0735-1097(95)00592-7

W. Weintraub, P. Mauldin, E. Becker, A. Kosinski, and S. King, A Comparison of the Costs of and Quality of Life After Coronary Angioplasty or Coronary Surgery for Multivessel Coronary Artery Disease : Results From the Emory Angioplasty Versus Surgery Trial (EAST), Circulation, vol.92, issue.10, pp.2831-2840, 1995.
DOI : 10.1161/01.CIR.92.10.2831

W. Weintraub, E. Becker, P. Mauldin, S. Culler, A. Kosinski et al., Costs of revascularization over eight years in the randomized and eligible patients in the emory angioplasty versus surgery trial (EAST), The American Journal of Cardiology, vol.86, issue.7, pp.747-752, 2000.
DOI : 10.1016/S0002-9149(00)01074-2

M. Hlatky, D. Boothroyd, K. Melsop, M. Brooks, D. Mark et al., Medical Costs and Quality of Life 10 to 12 Years After Randomization to Angioplasty or Bypass Surgery for Multivessel Coronary Artery Disease, Circulation, vol.110, issue.14, pp.1960-1966, 2004.
DOI : 10.1161/01.CIR.0000143379.26342.5C

M. Sculpher, P. Seed, R. Henderson, M. Buxton, S. Pocock et al., Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial, The Lancet, vol.344, issue.8927, pp.927-930, 1994.
DOI : 10.1016/S0140-6736(94)92274-8

R. Henderson, S. Pocock, S. Sharp, K. Nanchahal, M. Sculpher et al., Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting, The Lancet, vol.352, issue.9138, pp.1419-1425, 1998.
DOI : 10.1016/S0140-6736(98)03358-3

D. Cohen, T. Lavelle, V. Hout, B. Li, H. Lei et al., Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: One-year results from the SYNTAX trial, Catheterization and Cardiovascular Interventions, vol.362, issue.2, pp.198-209, 2012.
DOI : 10.1002/ccd.23147

S. Kinlay, Cost-effectiveness of coronary angioplasty versus medical treatment: the impact of cost-shifting, Australian and New Zealand Journal of Medicine, vol.55, issue.1, pp.20-26, 1996.
DOI : 10.1111/j.1445-5994.1996.tb02902.x

P. Steg, C. Thuaire, D. Himbert, D. Carrié, S. Champagne et al., DECOPI (DEsobstruction COronaire en Post-Infarctus): A Randomized Multi-centre Trial of Occluded Artery Angioplasty After Acute Myocardial Infarction, ACC Current Journal Review, vol.14, issue.5, pp.2187-2194, 2004.
DOI : 10.1016/j.accreview.2005.04.023

M. Sculpher, D. Smith, T. Clayton, R. Henderson, M. Buxton et al., Coronary angioplasty versus medical therapy for angina. Health service costs based on the second Randomized Intervention Treatment of Angina (RITA-2) trial, European Heart Journal, vol.23, issue.16, pp.1291-1300, 2002.
DOI : 10.1053/euhj.2001.3075

B. Reeves, G. Angelini, A. Bryan, F. Taylor, T. Cripps et al., A multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery, Health Technology Assessment, vol.8, issue.16, pp.1-43, 2004.
DOI : 10.3310/hta8160

D. Cohen, H. Krumholz, C. Sukin, K. Ho, R. Siegrist et al., In-Hospital and One-Year Economic Outcomes After Coronary Stenting or Balloon Angioplasty : Results From a Randomized Clinical Trial, Circulation, vol.92, issue.9, pp.2480-2487, 1995.
DOI : 10.1161/01.CIR.92.9.2480

P. Serruys, B. Van-hout, H. Bonnier, V. Legrand, E. Garcia et al., Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II), The Lancet, vol.352, issue.9129, pp.673-681, 1998.
DOI : 10.1016/S0140-6736(97)11128-X

A. Bakhai, G. Stone, E. Mahoney, T. Lavelle, C. Shi et al., Cost Effectiveness of Paclitaxel-Eluting Stents for Patients Undergoing Percutaneous Coronary Revascularization, Journal of the American College of Cardiology, vol.48, issue.2, pp.253-261, 2006.
DOI : 10.1016/j.jacc.2006.02.063

B. Van-hout, P. Serruys, P. Lemos, M. Van-den-brand, G. Van-es et al., One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial, Heart, vol.91, issue.4, pp.507-512, 2005.
DOI : 10.1136/hrt.2004.034454

G. Salanti, J. Higgins, A. Ades, and J. Ioannidis, Evaluation of networks of randomized trials, Statistical Methods in Medical Research, vol.21, issue.11, pp.279-301, 2008.
DOI : 10.1177/0962280207080643

B. Psaty, T. Lumley, C. Furberg, G. Schellenbaum, M. Pahor et al., Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents, JAMA, vol.289, issue.19, pp.2534-2544, 2003.
DOI : 10.1001/jama.289.19.2534

H. Blasco-fontecilla, M. Perez-rodriguez, R. Garcia-nieto, P. Fernandez-navarro, H. Galfalvy et al., Worldwide impact of economic cycles on suicide trends over 3???decades: differences according to level of development. A mixed effect model study, BMJ Open, vol.2, issue.3, p.201222586285, 2012.
DOI : 10.1136/bmjopen-2011-000785

A. Cameron, A. Bansal, T. Dua, S. Hill, S. Moshe et al., Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries, Epilepsia, vol.10, issue.6, pp.962-969, 2012.
DOI : 10.1111/j.1528-1167.2012.03446.x

M. Pirson, L. Schenker, D. Martins, D. Dung, J. Chalé et al., What can we learn from international comparisons of costs by DRG? Eur, J. Heal. Econ. Hepac Heal. Econ. Prev. Care [Internet], p.2012, 2012.

E. Villanueva, J. Wasiak, and E. Petherick, Percutaneous transluminal rotational atherectomy for coronary artery disease, Cochrane Database Syst. Rev. Online, vol.82, issue.5, p.3334, 2003.
DOI : 10.1002/14651858.CD003334

J. Greenhalgh, J. Hockenhull, N. Rao, Y. Dundar, R. Dickson et al., Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes, Cochrane Database Syst. Rev. Online, vol.4, issue.4, p.4587, 2010.
DOI : 10.1002/14651858.CD004587.pub2

M. Drummond and T. Jefferson, Guidelines for authors and peer reviewers of economic submissions to the BMJ, BMJ, vol.313, issue.7052, pp.275-283, 1996.
DOI : 10.1136/bmj.313.7052.275

M. Stevenson, L. , M. Morgan, M. Wong, and R. , Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcoholrelated liver disease: a systematic review and economic evaluation, Heal. Technol. Assess. Winch. Engl, vol.16, pp.1-174, 2012.

D. Moher, L. Weeks, M. Ocampo, D. Seely, M. Sampson et al., Describing reporting guidelines for health research: a systematic review, Journal of Clinical Epidemiology, vol.64, issue.7, pp.718-742, 2011.
DOI : 10.1016/j.jclinepi.2010.09.013

C. Boonacker, P. Broos, E. Sanders, A. Schilder, and M. Rovers, Cost Effectiveness of Pneumococcal Conjugate Vaccination against Acute Otitis Media in Children, PharmacoEconomics, vol.69, issue.8, pp.199-211, 2011.
DOI : 10.2165/11584930-000000000-00000

B. Woods, N. Hawkins, and D. Scott, Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: A tutorial, BMC Medical Research Methodology, vol.60, issue.5, p.54, 2010.
DOI : 10.1016/j.jclinepi.2006.09.009

G. Lu and A. Ades, Combination of direct and indirect evidence in mixed treatment comparisons, Statistics in Medicine, vol.48, issue.20, pp.3105-3124, 2004.
DOI : 10.1002/sim.1875

J. Higgins and A. Whitehead, BORROWING STRENGTH FROM EXTERNAL TRIALS IN A META-ANALYSIS, Statistics in Medicine, vol.15, issue.24, pp.2733-2749, 1996.
DOI : 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0

T. Smith, D. Spiegelhalter, and A. Thomas, Bayesian approaches to random-effects meta-analysis: A comparative study, Statistics in Medicine, vol.307, issue.24, pp.2685-2699, 1995.
DOI : 10.1002/sim.4780142408

G. Lu, A. Ades, A. Sutton, N. Cooper, A. Briggs et al., Meta-analysis of mixed treatment comparisons at multiple follow-up times, Statistics in Medicine, vol.25, issue.20, pp.3681-3699, 2007.
DOI : 10.1002/sim.2831

M. Hlatky, D. Boothroyd, M. Brooks, C. Winston, A. Rosen et al., Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty, American Heart Journal, vol.138, issue.2, pp.376-383, 1999.
DOI : 10.1016/S0002-8703(99)70128-6

I. Meredith and W. Wijns, Clinical Trial Update. ENDEAVOR I & II clinical program: long term follow-up, 2005.

I. Meredith, Trial updates & long term follow-up -ENDEAVOR I: 3-year, ENDEAVOR II: 2-year clinical results, 2006.

A. Zeiher, ENDEAVOR clinical Program Update. ENDEAVOR I: 4-year clinical follow-up. ENDEAVOR II: 3-year clinical follow-up, 2007.

W. Brouwer, L. Niessen, M. Postma, and F. Rutten, Need for differential discounting of costs and health effects in cost effectiveness analyses, BMJ, vol.331, issue.7514, pp.446-448, 2005.
DOI : 10.1136/bmj.331.7514.446

S. Simoens, Health Economic Assessment: A Methodological Primer, International Journal of Environmental Research and Public Health, vol.6, issue.12, pp.2950-2966, 2009.
DOI : 10.3390/ijerph6122950

E. Eisenstein, M. Leon, D. Kandzari, L. Mauri, R. Edwards et al., Long-Term Clinical and Economic Analysis of the Endeavor Zotarolimus-Eluting Stent Versus the Cypher Sirolimus-Eluting Stent, Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions), pp.1199-1207, 2009.
DOI : 10.1016/j.jcin.2009.10.009

B. 2d, S. Group, R. Frye, P. August, M. Brooks et al., A randomized trial of therapies for type 2 diabetes and coronary artery disease, N. Engl. J. Med, vol.360, pp.2503-2515, 2009.

M. Hlatky, D. Boothroyd, K. Melsop, L. Kennedy, C. Rihal et al., Economic Outcomes of Treatment Strategies for Type 2 Diabetes Mellitus and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial, Circulation, vol.120, issue.25, pp.2550-2558, 2009.
DOI : 10.1161/CIRCULATIONAHA.109.912709

S. Reed, K. Anstrom, A. Bakhai, A. Briggs, R. Califf et al., Conducting economic evaluations alongside multinational clinical trials: Toward a research consensus, American Heart Journal, vol.149, issue.3, pp.434-443, 2005.
DOI : 10.1016/j.ahj.2004.11.001

L. Campeau, M. Enjalbert, J. Lespérance, C. Vaislic, C. Grondin et al., Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery, Circulation, vol.68, pp.1-7, 1983.

A. Cameron, G. Green, D. Brogno, and J. Thornton, Internal thoracic artery grafts: 20-year clinical follow-up, Journal of the American College of Cardiology, vol.25, issue.1, pp.188-192, 1995.
DOI : 10.1016/0735-1097(94)00332-K

URL : http://doi.org/10.1016/0735-1097(94)00332-k

G. Fitzgibbon, H. Kafka, A. Leach, W. Keon, G. Hooper et al., Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years, Journal of the American College of Cardiology, vol.28, issue.3, pp.616-626, 1996.
DOI : 10.1016/0735-1097(96)00206-9

M. Shelton, M. Forman, R. Virmani, A. Bajaj, W. Stoney et al., A comparison of morphologic and angiographic findings in long-term internal mammary artery and saphenous vein bypass grafts, Journal of the American College of Cardiology, vol.11, issue.2, pp.297-307, 1988.
DOI : 10.1016/0735-1097(88)90094-0

A. Schömig, A. Dibra, S. Windecker, J. Mehilli, J. Suárez-de-lezo et al., A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease, Journal of the American College of Cardiology, vol.50, issue.14, pp.1373-1380, 2007.
DOI : 10.1016/j.jacc.2007.06.047

H. Gurm, T. Boyden, and K. Welch, Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: A meta-analysis, American Heart Journal, vol.155, issue.4, pp.630-639, 2008.
DOI : 10.1016/j.ahj.2007.11.021

G. Wei, Y. Fang, R. Yaqi, C. Lin, and W. Ningfu, Clinical outcomes of zotarolimus-eluting stents versus the first generation sirolimus-eluting stents and paclitaxel-eluting stents: A meta-analysis of randomized trials, International Journal of Cardiology, vol.157, issue.1, pp.152-156, 2012.
DOI : 10.1016/j.ijcard.2012.03.020

P. Serruys, A. Ong, L. Van-herwerden, J. Sousa, A. Jatene et al., Five-Year Outcomes After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease: The Final Analysis of the Arterial Revascularization Therapies Study (ARTS) Randomized Trial, ACC Current Journal Review, vol.14, issue.12, pp.575-581, 2005.
DOI : 10.1016/j.accreview.2005.11.072

F. Cuculi, A. Banning, A. Abizaid, A. Bartorelli, A. Baux et al., Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry, EuroIntervention, vol.7, issue.8, pp.962-968, 2011.
DOI : 10.4244/EIJV7I8A152

M. Lenzen, E. Boersma, M. Bertrand, W. Maier, C. Moris et al., Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization, European Heart Journal, vol.26, issue.12, pp.1169-1179, 2005.
DOI : 10.1093/eurheartj/ehi238

C. Hamm, J. Reimers, T. Ischinger, H. Rupprecht, J. Berger et al., A Randomized Study of Coronary Angioplasty Compared with Bypass Surgery in Patients with Symptomatic Multivessel Coronary Disease, New England Journal of Medicine, vol.331, issue.16, pp.1037-1043, 1994.
DOI : 10.1056/NEJM199410203311601

R. Applegate, J. Hermiller, M. Sanz, J. Doostzadeh, W. Pierson et al., Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial, EuroIntervention, vol.6, issue.4, pp.437-446, 2010.
DOI : 10.4244/EIJ30V6I4A75

P. Serruys, M. Morice, A. Kappetein, A. Colombo, D. Holmes et al., Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease, New England Journal of Medicine, vol.360, issue.10, pp.961-972, 2009.
DOI : 10.1056/NEJMoa0804626

S. Head, D. Holmes, . Jr, M. Mack, P. Serruys et al., Risk Profile and 3-Year Outcomes From the SYNTAX Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting Nested Registries, JACC: Cardiovascular Interventions, vol.5, issue.6, pp.618-625, 2012.
DOI : 10.1016/j.jcin.2012.02.013

M. Hanssen, Y. Cottin, K. Khalife, L. Hammer, P. Goldstein et al., French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010, Heart, vol.98, issue.9, pp.699-705, 2010.
DOI : 10.1136/heartjnl-2012-301700

S. Willich, F. Müller-riemenschneider, D. Mcbride, S. Silber, K. Kuck et al., Gesundheits??konomische Evalution von medikamentenfreisetzenden Stents, Herz, vol.36, issue.1, p.2012, 2012.
DOI : 10.1007/s00059-012-3581-5

E. Varani, M. Balducelli, C. Gatti, M. Tesselli, G. Vecchi et al., Cost of singlevessel and multivessel coronary drug-eluting stenting: comparison to the DRG funding level, Ital. Heart J. Off. J. Ital. Fed. Cardiol, vol.6, pp.52-58, 2005.

C. Revascularization, W. Group, M. Patel, G. Dehmer, J. Hirshfeld et al., Appropriate Use Criteria Task Force American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association of Thoracic Surgery American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American College of Cardiology Foundation J. Thorac. Cardiovasc. Surg, vol.143, pp.780-803, 2012.

M. Patel, G. Dehmer, J. Hirshfeld, P. Smith, J. A. Spertus et al., ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography, pp.530-553, 2009.
DOI : 10.1016/j.jacc.2008.10.005

D. Ko, H. Guo, H. Wijeysundera, M. Natarajan, A. Nagpal et al., Assessing the Association of Appropriateness of Coronary Revascularization and Clinical Outcomes for Patients With Stable Coronary Artery Disease, Journal of the American College of Cardiology, vol.60, issue.19, pp.1876-1884, 2012.
DOI : 10.1016/j.jacc.2012.06.056

P. Chan, M. Patel, L. Klein, R. Krone, G. Dehmer et al., Appropriateness of Percutaneous Coronary Intervention, JAMA, vol.306, issue.1, pp.53-61, 2011.
DOI : 10.1001/jama.2011.916

M. Rothberg, S. Sivalingam, J. Ashraf, P. Visintainer, J. Joelson et al., Patients' and Cardiologists' Perceptions of the Benefits of Percutaneous Coronary Intervention for Stable Coronary Disease, Annals of Internal Medicine, vol.153, issue.5, pp.307-313, 2010.
DOI : 10.7326/0003-4819-153-5-201009070-00005

A. Brennan, S. Chick, and R. Davies, A taxonomy of model structures for economic evaluation of health technologies, Health Economics, vol.24, issue.12, pp.1295-1310, 2006.
DOI : 10.1002/hec.1148

H. Autorité and D. Santé, Choix méthodologiques pour l'évaluation économique à la HASAvailable from: http://www.has-sante.fr/portail/jcms/c_1120711/choix- methodologiques-pour-l-evaluation-economique-a-la-has, 2011.